Pfizer Consumer Healthcare to expand Caltrate and Centrum production in China

Published: 22-Jun-2015
Estates & Facilities Dietary supplements Active Nutrition Food

New $95 million 'green' site expected to be LEED certified


Pfizer has announced that it broke ground for a $95 million consumer products production facility in Suzhou, China.

The new site is near the company’s existing Suzhou site and will help to increase production capacity to meet growing demand for Pfizer Consumer Healthcare’s brands in China and the Asia-Pacific region.

'Asia Pacific is a large and rapidly growing region for Pfizer Consumer Healthcare and our new plant in Suzhou will give us the production capacity we need to meet increasing demand for our brands, particularly in China,' said Andy Schmeltz, Regional President, Asia Pacific and Europe, Middle East and Africa, Pfizer Consumer Healthcare.

The new facility will primarily produce Caltrate dietary supplements, Centrum multivitamins and, in the future, will support the production of additional products. There are also plans to eventually house a research and development facility on the site to help support innovation in the region.

The site design is expected to achieve Leadership in Energy and Environmental Design (LEED) certification, and will incorporate the most advanced technologies to minimise energy and water consumption.

For instance, to minimise energy consumption, the plant will be fitted with high-efficiency manufacturing equipment, LED and solar powered lighting with automatic controls. It will employ technologies to recycle waste heating and cooling and will make extensive use of natural lighting and shading.

To conserve water, the plant will use high efficiency equipment and fixtures, recycle treated wastewater for its cooling tower and for toilets and capture rain water for irrigation of its lawn and landscaping.

'This new site is the latest step on our journey of environmental sustainability,' said Tony Maddaluna, Executive Vice President and President of Pfizer Global Supply. 'For 15 years, we have voluntarily met or exceeded the public goals we have set to reduce our greenhouse gas emissions globally. This new facility is in keeping with that commitment to environmental stewardship.'

  • Companies:
  • Pfizer
See more

You may also like

Manufacturing

Sirio Pharma sells Treerly to Pfizer

Read more
Pfizer’s purchase of Treerly will help to enhance their market position in China’s nutrition and healthcare marketplace

Trending Articles

  1. Mythbusting study highlights the heart health benefits of omega-6 fatty acids A new report has highlighted the benefits of omega-6 intake — specifically linoleic acid — in reducing the risk of cardiovascular disease, type II diabetes and elevated cholesterol levels
  2. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  3. SAM-e supplement labelling discrepancies: where does the industry go from here? NBR caught up with NOW Foods' VP of Global Sales & Marketing, Dan Richard, to discuss the latest results of NOW's SAM-e supplement testing survey, and what it might mean for the nutraceutical industry

Upcoming event

Vitafoods India

5–7 February 2025 | Exhibition | Mumbai See all

You may also like

Manufacturing

Sirio Pharma sells Treerly to Pfizer

Pfizer’s purchase of Treerly will help to enhance their market position in China’s nutrition and healthcare marketplace
Regulatory

Chrondroitin outperforms celecoxib in knee osteoarthritis study

For the first time, chondroitin sulfate has been more successful than celecoxib in reducing the long-term progression of knee osteoarthritis (OA), according to new research findings
Regulatory

Chondroitin and glucosamine as effective as cox-2 inhibitors in treatment of osteoarthritis

Study shows that a particular chondroitin/glucosamine formula has comparable efficacy to celecoxib in reducing pain, stiffness and joint swelling in patients with painful knee OA
Training & Education

Probiotic trends and consumer preferences that are currently shaping the landscape

FMCG Gurus delves into consumer perceptions of probiotics, as well as how and why they like to consume them
Ingredients

Burcon and Puratos join forces to develop canola protein-based egg alternative

The two companies are aiming to develop Burcon's plant-based canola protein, Puratein, as an egg replacement solution in functional food bakery and patisserie products
Manufacturing

Alland & Robert continues to lead the way with gum acacia solutions that contribute to a healthier and more sustainable future

As the global leader and pioneer of natural gums, Alland & Robert is focused on creating ingredients for a healthier tomorrow and providing tailor-made support for innovation projects
Regulatory

Prenatal supplements often lack in nutrients essential for a healthy pregnancy, study reveals

Researchers found that many supplements lacked choline and iodine, which are crucial minerals in pregnancy, while some supplements contained harmful levels of toxic metals
Subscribe now